NCT00860600View on ClinicalTrials.gov

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Idiopathic Thrombocytopenic Purpura (ITP)
Interventions
DRUG

PG2

500mg/vial, iv infusion, 3 \~ 5 times/week, 2.5 \~ 3.5 hr/time

Trial Locations (4)

100

National Taiwan University Hospital, Taipei

500

Changhua Christian Hospital, Changhua

704

National Cheng Kung University Hospital, Tainan City

807

Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung City

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY